SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-074340
Filing Date
2021-05-28
Accepted
2021-05-28 17:25:44
Documents
2
Period of Report
2021-05-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2117679d1_8k.htm 8-K 23093
2 EXHIBIT 99.1 tm2117679d1_ex99-1.htm EX-99.1 7253
  Complete submission text file 0001104659-21-074340.txt   31533
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40119 | Film No.: 21981781
SIC: 6770 Blank Checks